Cervical Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Overview
Magnitude of Effect: Among women without cervices, fewer than 1 per 1,000 had abnormal Pap test results.
|Study Design: Evidence obtained from a single cohort study.|
|Internal Validity: Good.|
|External Validity: Good.|
- Sasieni P, Castanon A, Cuzick J: Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 339: b2968, 2009.
- Sawaya GF, McConnell KJ, Kulasingam SL, et al.: Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349 (16): 1501-9, 2003.
- Sankaranarayanan R, Nene BM, Shastri SS, et al.: HPV screening for cervical cancer in rural India. N Engl J Med 360 (14): 1385-94, 2009.
- Szarewski A: Cervical screening by visual inspection with acetic acid. Lancet 370 (9585): 365-6, 2007.
- Chen HC, Schiffman M, Lin CY, et al.: Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 103 (18): 1387-96, 2011.
WebMD Public Information from the National Cancer Institute
February 25, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this
Cervical Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] Topics